DE69229103T2 - Verfahren zur herstellung und verwendung von 1alpha,24-dihydroxy vitamin-d2 - Google Patents

Verfahren zur herstellung und verwendung von 1alpha,24-dihydroxy vitamin-d2

Info

Publication number
DE69229103T2
DE69229103T2 DE69229103T DE69229103T DE69229103T2 DE 69229103 T2 DE69229103 T2 DE 69229103T2 DE 69229103 T DE69229103 T DE 69229103T DE 69229103 T DE69229103 T DE 69229103T DE 69229103 T2 DE69229103 T2 DE 69229103T2
Authority
DE
Germany
Prior art keywords
dihydroxy vitamin
proportional
converted
1alpha
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69229103T
Other languages
English (en)
Other versions
DE69229103D1 (de
Inventor
Charles W Bishop
Glenville Jones
Joyce C Knutson
Robert M Moriarty
Raju Penmasta
Stephen Strugnell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bone Care International Inc
Original Assignee
Bone Care International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bone Care International Inc filed Critical Bone Care International Inc
Publication of DE69229103D1 publication Critical patent/DE69229103D1/de
Application granted granted Critical
Publication of DE69229103T2 publication Critical patent/DE69229103T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DE69229103T 1991-01-08 1992-01-07 Verfahren zur herstellung und verwendung von 1alpha,24-dihydroxy vitamin-d2 Expired - Lifetime DE69229103T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63786791A 1991-01-08 1991-01-08
PCT/US1992/000313 WO1992012165A1 (en) 1991-01-08 1992-01-07 METHODS FOR PREPARATION AND USE OF 1α,24-DIHYDROXY VITAMIN D¿2?

Publications (2)

Publication Number Publication Date
DE69229103D1 DE69229103D1 (de) 1999-06-10
DE69229103T2 true DE69229103T2 (de) 1999-10-14

Family

ID=24557692

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69229103T Expired - Lifetime DE69229103T2 (de) 1991-01-08 1992-01-07 Verfahren zur herstellung und verwendung von 1alpha,24-dihydroxy vitamin-d2
DE69233074T Expired - Lifetime DE69233074T2 (de) 1991-01-08 1992-01-07 Verfahren zur Herstellung von 1-alpha-24-dihydroxy-Vitamin D2

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69233074T Expired - Lifetime DE69233074T2 (de) 1991-01-08 1992-01-07 Verfahren zur Herstellung von 1-alpha-24-dihydroxy-Vitamin D2

Country Status (14)

Country Link
US (1) US6211168B1 (de)
EP (2) EP0914825B1 (de)
CN (3) CN1032256C (de)
AT (2) ATE240736T1 (de)
AU (1) AU1247592A (de)
DE (2) DE69229103T2 (de)
DK (1) DK0550702T3 (de)
ES (2) ES2200238T3 (de)
GR (1) GR3030466T3 (de)
MX (1) MX9200070A (de)
NZ (1) NZ241255A (de)
PT (1) PT99998B (de)
WO (1) WO1992012165A1 (de)
ZA (1) ZA92108B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602116A (en) * 1988-08-02 1997-02-11 Bone Care International, Inc. Method for treating and preventing secondary hyperparathyroidism
US20040009958A1 (en) * 1991-01-08 2004-01-15 Bone Care International, Inc. Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
DE69325253T2 (de) * 1992-08-28 1999-12-02 Bone Care Int Inc 1alpha,24(s)-dihydroxy vitamin d2, seine synthese und verwendung
US5763429A (en) 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US6376479B1 (en) 1995-04-03 2002-04-23 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
PL336231A1 (en) 1997-02-13 2000-06-19 Bone Care International System for aimed therapeutic delivery of vitamin d compounds
US20030129194A1 (en) * 1997-02-13 2003-07-10 Bone Care International, Inc. Targeted therapeutic delivery of vitamin D compounds
US6087350A (en) * 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
CA2326117A1 (en) * 1998-03-27 1999-10-07 Oregon Health Sciences University Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders
JP2002516306A (ja) * 1998-05-29 2002-06-04 ボーン ケア インターナショナル インコーポレイテッド ヒドロキシ−２５−エン−ビタミンｄ化合物の製造方法
JP2004504295A (ja) * 2000-07-18 2004-02-12 ボーン　ケア　インターナショナル　インコーポレイテッド 安定化１α−ヒドロキシビタミンＤ
IL162920A0 (en) 2002-01-10 2005-11-20 Va Pharmaceutical Ind Ltd Selective enzymatic esterification and solvolysis of epimeric vitamin d analog and separation of theepimers
US20060003950A1 (en) * 2004-06-30 2006-01-05 Bone Care International, Inc. Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
US7094775B2 (en) * 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
MX2007000093A (es) * 2004-07-01 2007-06-14 Teva Pharma Formas cristalinas de 1,24(s)-dihidroxi vitamina d2.
CN101607931B (zh) * 2009-07-23 2012-01-11 青岛正大海尔制药有限公司 一种骨化三醇的制备方法
CN103122009B (zh) * 2013-01-09 2015-11-25 江苏吉贝尔药业股份有限公司 两种用于合成他卡西醇支链的重要中间体化合物
CN103012463B (zh) * 2013-01-17 2016-02-10 南京理工大学 (s)-3-甲基-2-(叔丁基二甲基硅氧基)-1-溴丁烷的合成方法
CN104496871B (zh) * 2014-12-22 2016-03-09 上海皓元生物医药科技有限公司 一种他卡西醇的制备方法
CN109627279A (zh) * 2019-02-01 2019-04-16 浙江花园营养科技有限公司 一种活性维生素d3中间体的制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US467190A (en) * 1892-01-19 Bernard g
US4670190A (en) * 1973-01-10 1987-06-02 Hesse Robert H 1-α-hydroxy vitamin D compounds and process for preparing same
US3880894A (en) 1974-05-24 1975-04-29 Wisconsin Alumni Res Found 1,25-Dihydroxyergocalciferol
US4022891A (en) * 1974-06-18 1977-05-10 Teijin Limited Novel 1α,24-dihydroxycholecalciferol compositions, novel precursors thereof, and processes for preparing them
US3970676A (en) * 1974-10-29 1976-07-20 The Upjohn Company Novel process and intermediate compounds used is preparation of -Δ5,7- steroid dienes
GB1583749A (en) * 1976-06-03 1981-02-04 Res Inst Medicine Chem Vitamin d derivatives
US4195027A (en) * 1978-01-16 1980-03-25 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
US4225596A (en) * 1978-10-13 1980-09-30 Wisconsin Alumni Research Foundation Method for treating calcium imbalance and improving calcium absorption in mammals
JPS55136229A (en) * 1979-04-10 1980-10-23 Teijin Ltd Adjustment of bone metabolism in warm-blooded animal and drug for it
US4310511A (en) * 1980-10-02 1982-01-12 Massachusetts General Hospital Sunscreen compositions containing Δ5,7 steroidal dienes
US4338250A (en) * 1981-04-27 1982-07-06 Wisconsin Alumni Research Foundation 1-Hydroxylation process
US4448721A (en) * 1982-09-20 1984-05-15 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 compounds and process for preparing same
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
US4719205A (en) 1984-01-30 1988-01-12 Wisconsin Alumini Research Foundation Side-chain unsaturated 1-hydroxyvitamin D compounds
US4588528A (en) * 1984-05-31 1986-05-13 Wisconsin Alumni Research Foundation 1,24-dihydroxy-Δ22 -vitamin D3 and process for preparing same
US4728643A (en) * 1984-11-02 1988-03-01 The General Hospital Corporation Method of treating psoriasis
WO1987000834A1 (en) * 1985-08-02 1987-02-12 Leo Pharmaceutical Products Ltd. A/S Novel vitamin d analogues
JPH0755960B2 (ja) * 1986-11-14 1995-06-14 日清製粉株式会社 ステロイド誘導体およびその製造方法
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US5104864A (en) * 1988-08-02 1992-04-14 Bone Care International, Inc. Method for treating and preventing loss of bone mass
US5242824A (en) * 1988-12-22 1993-09-07 Oncogen Monoclonal antibody to human carcinomas
US5098899A (en) * 1989-03-06 1992-03-24 Trustees Of Boston University Method for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites

Also Published As

Publication number Publication date
ES2134207T3 (es) 1999-10-01
EP0914825A2 (de) 1999-05-12
WO1992012165A1 (en) 1992-07-23
ES2200238T3 (es) 2004-03-01
EP0914825B1 (de) 2003-05-21
ATE179604T1 (de) 1999-05-15
DE69233074D1 (de) 2003-06-26
EP0914825A3 (de) 1999-05-19
DE69229103D1 (de) 1999-06-10
CN1071574C (zh) 2001-09-26
PT99998A (pt) 1993-01-29
CN1133712A (zh) 1996-10-23
DE69233074T2 (de) 2004-03-18
NZ241255A (en) 1999-05-28
GR3030466T3 (en) 1999-10-29
EP0550702A1 (de) 1993-07-14
CN1067243A (zh) 1992-12-23
ATE240736T1 (de) 2003-06-15
CN1032256C (zh) 1996-07-10
DK0550702T3 (da) 1999-11-01
ZA92108B (en) 1992-10-28
AU1247592A (en) 1992-08-17
CN1143500A (zh) 1997-02-26
MX9200070A (es) 1992-07-01
PT99998B (pt) 1999-06-30
CN1078072C (zh) 2002-01-23
EP0550702A4 (en) 1994-06-08
US6211168B1 (en) 2001-04-03
EP0550702B1 (de) 1999-05-06

Similar Documents

Publication Publication Date Title
DE69229103D1 (de) Verfahren zur herstellung und verwendung von 1alpha,24-dihydroxy vitamin-d2
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
NO921955L (no) Nye d-vitaminforbindelser og fremgangsmaate til fremstilling av samme
DE69325253D1 (de) 1alpha,24(s)-dihydroxy vitamin d2, seine synthese und verwendung
WO1994005630B1 (en) 1α,24(S)-DIHYDROXY VITAMIN D2, ITS FORMATION AND USE
ATE86978T1 (de) Verfahren zur herstellung von 3,5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer.
DE69130497T2 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
ATE177111T1 (de) Doppelbindungs-isomer von equilin erhalten durch säure-isomerisierung
ATE201024T1 (de) Carbamatderivate von 4-amino-3-isoxazolidinonen und 3-amino-1-hydroxypyrrolidinon-2-onen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3768747D1 (de) Aminosaeureester von cycloaliphatischen alkoholen, verfahren zur herstellung und verwendung als arzneimittel.
ATE220915T1 (de) Einen basischen fibroblastwachstumsfaktor enthaltende mittel zur behandlung von knochenkrankheiten
ATE131155T1 (de) Verfahren zur herstellung von zwischenprodukten und zur synthese von n-(2-hydroxyethyl)-2- hydroxymethyl-3,4,5-trihydroxypiperidine.
ATE207482T1 (de) Verfahren zur herstellung von n2-arylsulfonyl-l- argininamiden
DE69404932T2 (de) Zwischenprodukte zur Herstellung von Vitamin A und von Carotenoiden und Verfahren zu deren Herstellung
DE69405507D1 (de) Zwischenprodukte zur Herstellung von Vitamin A und von Carotenoiden und Verfahren zu deren Herstellung
ATE147267T1 (de) Verwendung von 24,25-dihydroxyvitamin-d3 zur herstellung eines arzneimittel zur behandlung der rachitis
DK0551653T3 (da) Enantiomeric pure cis-2-oxa-5,8-diazabicyclo(4.3.0)nonanes and process for their preparation
DE69108319T2 (de) Verfahren zur herstellung von vitamin-d2-verbindungen und ihrer 1-alpha hydrogenierten derivate.
ATE157008T1 (de) Aluminium-kalium-sulfat enthaltende creme und verfahren zur herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition